Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3802 | 1830 | 45.2 | 70% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
75 | 27074 | SUBSTANCE ABUSE//JOURNAL OF SUBSTANCE ABUSE TREATMENT//BUPRENORPHINE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | ACAMPROSATE | Author keyword | 221 | 72% | 10% | 174 |
2 | NALTREXONE | Author keyword | 78 | 22% | 17% | 314 |
3 | NALMEFENE | Author keyword | 18 | 43% | 2% | 32 |
4 | DISULFIRAM | Author keyword | 12 | 17% | 3% | 64 |
5 | ALCOHOLISM TREATMENT | Author keyword | 8 | 33% | 1% | 21 |
6 | CAMPRAL | Author keyword | 6 | 100% | 0% | 4 |
7 | TRAJECTORY BASED ANALYSIS | Author keyword | 6 | 100% | 0% | 4 |
8 | TREATMENT RECOVERY | Address | 5 | 40% | 1% | 10 |
9 | ALCOHOL DETERRENTS | Author keyword | 5 | 63% | 0% | 5 |
10 | EXTENDED RELEASE NALTREXONE | Author keyword | 5 | 41% | 0% | 9 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | ACAMPROSATE | 221 | 72% | 10% | 174 | Search ACAMPROSATE | Search ACAMPROSATE |
2 | NALTREXONE | 78 | 22% | 17% | 314 | Search NALTREXONE | Search NALTREXONE |
3 | NALMEFENE | 18 | 43% | 2% | 32 | Search NALMEFENE | Search NALMEFENE |
4 | DISULFIRAM | 12 | 17% | 3% | 64 | Search DISULFIRAM | Search DISULFIRAM |
5 | ALCOHOLISM TREATMENT | 8 | 33% | 1% | 21 | Search ALCOHOLISM+TREATMENT | Search ALCOHOLISM+TREATMENT |
6 | CAMPRAL | 6 | 100% | 0% | 4 | Search CAMPRAL | Search CAMPRAL |
7 | TRAJECTORY BASED ANALYSIS | 6 | 100% | 0% | 4 | Search TRAJECTORY+BASED+ANALYSIS | Search TRAJECTORY+BASED+ANALYSIS |
8 | ALCOHOL DETERRENTS | 5 | 63% | 0% | 5 | Search ALCOHOL+DETERRENTS | Search ALCOHOL+DETERRENTS |
9 | EXTENDED RELEASE NALTREXONE | 5 | 41% | 0% | 9 | Search EXTENDED+RELEASE+NALTREXONE | Search EXTENDED+RELEASE+NALTREXONE |
10 | OPIOID ANTAGONISTS | 5 | 19% | 1% | 22 | Search OPIOID+ANTAGONISTS | Search OPIOID+ANTAGONISTS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | WEANED ALCOHOLICS | 122 | 88% | 3% | 58 |
2 | ACAMPROSATE | 98 | 51% | 7% | 136 |
3 | NALTREXONE | 74 | 20% | 18% | 323 |
4 | CA ACETYL HOMOTAURINATE | 57 | 95% | 1% | 19 |
5 | DISULFIRAM TREATMENT | 53 | 63% | 3% | 53 |
6 | TESTING COMBINED PHARMACOTHERAPIES | 45 | 94% | 1% | 16 |
7 | CONSUMMATORY BEHAVIORS | 45 | 68% | 2% | 39 |
8 | OUTPATIENT ALCOHOLICS | 40 | 79% | 1% | 26 |
9 | ORAL NALMEFENE | 34 | 69% | 2% | 29 |
10 | BETA ENDORPHIN SYSTEM | 33 | 74% | 1% | 25 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Pharmacotherapy for Adults With Alcohol Use Disorders in Outpatient Settings A Systematic Review and Meta-analysis | 2014 | 32 | 81 | 65% |
Association of mu-opioid receptor (OPRM1) gene polymorphism with response to naltrexone in alcohol dependence: a systematic review and meta-analysis | 2012 | 42 | 36 | 69% |
Efficacy and Tolerability of Naltrexone in the Management of Alcohol Dependence | 2010 | 37 | 33 | 97% |
Pharmacological treatment of alcohol dependence - A review of the evidence | 1999 | 248 | 47 | 85% |
Acamprosate for alcohol dependence | 2010 | 56 | 93 | 66% |
Clinical and biological moderators of response to naltrexone in alcohol dependence: a systematic review of the evidence | 2014 | 9 | 44 | 77% |
Opioid antagonists for alcohol dependence | 2010 | 56 | 145 | 63% |
Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials | 2005 | 95 | 50 | 88% |
Pharmacotherapy of Alcohol Use Disorders: Seventy-Five Years of Progress | 2014 | 9 | 82 | 71% |
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings | 2008 | 112 | 225 | 47% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TREATMENT RECOVERY | 5 | 40% | 0.5% | 10 |
2 | ADDICT BEHAV ADDICT MED | 4 | 11% | 1.8% | 33 |
3 | SW TEXAS ADDICT TECHNOL | 3 | 100% | 0.2% | 3 |
4 | TREATMENT STUDIES ADDICT | 3 | 100% | 0.2% | 3 |
5 | COMMUNITY MED HEALTHCARE | 3 | 30% | 0.5% | 9 |
6 | STUDIES ADDICT | 3 | 14% | 0.9% | 17 |
7 | STUDY ADDICT | 2 | 20% | 0.6% | 11 |
8 | PEARSON ALCOHOLISM ADDICT | 2 | 32% | 0.3% | 6 |
9 | SUBST ABUSE N TEXAS | 2 | 67% | 0.1% | 2 |
10 | SUBST ABUSE TREATMENT UNIT | 2 | 27% | 0.3% | 6 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000149507 | PORTLAND ALCOHOL//ALCOHOL//ALCOHOL PREFERENCE |
2 | 0.0000132466 | BACLOFEN//CGP44532//POSTSYNAPTIC DOPAMINE RECEPTOR SUPERSENSITIVITY |
3 | 0.0000130266 | ALCOHOL WITHDRAWAL SYNDROME//DELIRIUM TREMENS//ALCOHOL WITHDRAWAL DELIRIUM |
4 | 0.0000112897 | LOFEXIDINE//NALTREXONE//UNIT EDUC DRUGS ALCOHOL |
5 | 0.0000100148 | PROV DROGODEPENDENCIAS GRANADA//EMAC EA4360//F SOZU |
6 | 0.0000091965 | OPRM1//A118G//OPRM1 GENE |
7 | 0.0000086925 | SALVINORIN A//SALVIA DIVINORUM//KAPPA OPIOID RECEPTOR |
8 | 0.0000081100 | RO15 4513//RAPID TOLERANCE//ETHANOL WITHDRAWAL |
9 | 0.0000079601 | SUBSTANCE INDUCED DISORDERS//CLIN ALCOHOL DRUG SECT//FAIRVIEW RIVERSIDE HOSP |
10 | 0.0000075412 | DATCAP//EPIDEMIOL PUBL HLTH D93//COST OFFSET |